Point72 Middle East FZE’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16,651	Closed	-$2.95M	–	922
2023 Q3	$2.95M	Buy	16,651 +1,244	+8%	+$220K	0.1%	131
2023 Q2	$2.93M	Buy	+15,407	New	+$2.93M	0.08%	150